Literature DB >> 9792028

The mechanisms of hepatic sinusoidal endothelial cell regeneration: a possible communication system associated with vascular endothelial growth factor in liver cells.

S Mochida1, K Ishikawa, K Toshima, M Inao, H Ikeda, A Matsui, M Shibuya, K Fujiwara.   

Abstract

Vascular endothelial growth factor (VEGF) has been shown to induce proliferation of sinusoidal endothelial cells in primary culture. To elucidate the mechanisms of sinusoidal endothelial cell regeneration in vivo, mRNA expression of VEGF and its receptors, flt-1 and KDR/flk-1, were studied in rat livers. Northern blot analysis revealed that VEGF-mRNA was expressed in hepatocytes immediately after isolation from normal rats. In contrast, non-parenchymal cells, including sinusoidal endothelial cells, expressed VEGF receptor-mRNA. Vascular endothelial growth factor-mRNA expression in hepatocytes was decreased during primary culture, but increased following a peak of DNA synthesis, induced by addition of epidermal growth factor or hepatocyte growth factor to the culture medium at 24 h of plating. In a 70% resected rat liver, VEGF-mRNA expression increased with a peak at 72 h after the operation, and mRNA expression of VEGF receptors between 72 and 168 h. In such a liver, mitosis was maximal in hepatocytes at 36 h and in sinusoidal endothelial cells at 96 h. Also, mRNA expression of both VEGF and its receptors was significantly increased in carbon tetrachloride-intoxicated rat liver compared with normal rat liver. Vascular endothelial growth factor expression was minimal in Kupffer cells isolated from normal rats, but marked in activated Kupffer cells and hepatic macrophages from the intoxicated rats. Vascular endothelial growth factor-mRNA expression was also increased in activated stellate cells from these rats and in the cells activated during primary culture compared with quiescent cells. We conclude that increased levels of VEGF expression in regenerating hepatocytes may contribute to the proliferation of sinusoidal endothelial cells in partially resected rat liver, probably through VEGF receptors up-regulated on the cells. Also, VEGF derived from activated Kupffer cells, hepatic macrophages and stellate cells may be involved in this proliferation in injured rat liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9792028

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

Review 1.  Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.

Authors:  Catherine Frenette; Robert Gish
Journal:  World J Gastroenterol       Date:  2012-02-14       Impact factor: 5.742

2.  Liver regeneration is an angiogenesis- associated phenomenon.

Authors:  Tom A Drixler; Mathys J Vogten; Ewan D Ritchie; Theo J M V van Vroonhoven; Martijn F B G Gebbink; Emile E Voest; Inne H M Borel Rinkes
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

3.  The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure.

Authors:  Tadashi Namisaki; Hitoshi Yoshiji; Ryuichi Noguchi; Yasuhide Ikenaka; Mitsuteru Kitade; Kosuke Kaji; Yusaku Shirai; Yosuke Aihara; Junichi Yoshii; Koji Yanase; Tatsuhiro Tsujimoto; Hideto Kawaratani; Hiroshi Fukui
Journal:  J Angiogenes Res       Date:  2010-08-24

4.  Markers of liver regeneration-the role of growth factors and cytokines: a systematic review.

Authors:  Katrin Hoffmann; Alexander Johannes Nagel; Kazukata Tanabe; Juri Fuchs; Karolin Dehlke; Omid Ghamarnejad; Anastasia Lemekhova; Arianeb Mehrabi
Journal:  BMC Surg       Date:  2020-02-12       Impact factor: 2.102

5.  Combined histomorphometric and gene-expression profiling applied to toxicology.

Authors:  Andres Kriete; Mary K Anderson; Brad Love; John Freund; James J Caffrey; M Brook Young; Timothy J Sendera; Scott R Magnuson; J Mark Braughler
Journal:  Genome Biol       Date:  2003-04-30       Impact factor: 13.583

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.